Tattoo inks in Australia contain potentially carcinogenic and toxic chemicals, with no current regulatory framework in place. Advanced spectrometry techniques revealed that none of the tested inks ...
Dr. Joseph Lackey, Technical Manager at LGC Standards, provides an in-depth look at how calibration strategy selection in ...
The first human spaceflight to the vicinity of the Moon since December 1972 is set to roll out to Launch Complex 39B at the ...
Shares in Sanofi were sliding today after a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis (MS). Along with what looks set to be ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the complete response letter, citing both efficacy and safety concerns—including a ...
Medicare covers various aspects of multiple sclerosis (MS) treatment, including medications, therapy, hospital stays, and medical equipment, but the specific coverage depends on the Medicare plan.
Selma Blair has been in remission for MS since 2021, but she still has to be proactive about her health. “A few years ago, I didn’t think I’d be here...” Blair said during a Feb. 6, 2025, appearance ...
Elsa Mendoza is the mother of Heisman Trophy winner and Indiana quarterback Fernando Mendoza. She has multiple sclerosis, and her sons raise money to fight the disease. Elsa Mendoza wrote a letter to ...